Therapeutic Expertise

QPS has broad experience across Phase I-IV clinical development in a wide range of therapeutic indications handling both drug, diagnostic and device trials, and contributing to numerous product approvals since our founding in 1995.

We have the most notable depth and breadth of late phase clinical expertise in the following top-tier indications:

CNS Disease Alzheimer’s Disease Brochure New Draft FDA Guidelines for Alzheimer´s Disease: Which Cognitive Testing Battery Guarantees Success? - May, 2013
QPS CNS Drug Development Whitepaper Serial CSF Sampling for PK and Biomarker Analysis - April, 2013
Imaging Methods for Alzheimer’s Disease - March, 2013
Serial CSF Sampling over a Period of 30 h via an Indwelling Spinal Catheter in Healthy Volunteers: Headache, Back Pain, Tolerability and Measured Acetylcholine Profile - March, 2013
Amorfix and QPS to Collaborate on Alzheimer's Disease Project - January, 2013
Endocrinology Diabetes Brochure Doug Kalman, Director of QPS MRA’s Nutrition/Endocrinology Department publishes Article on the Amino Acid Composition of Concentrated Protein Powders - August, 2014
Oncology Oncology Brochure Eric Solon Co-presents Poster at AACR (American Association for Cancer Research) Annual Meeting showing the Tissue Disposition Profile of a 2nd Generation Hypomethylating Agent - April, 2014
QPS Antibody Drug Conjugates Whitepaper ERK1/2 activation as a tractable biomarker during clinical evaluation of BRAF inhibitors and other inhibitors of the ERK1/2 pathway - July, 2012
Neurology Pain Management Brochure Postoperative Cognitive Dysfunction (POCD) - April, 2013
Respiratory Respiratory Brochure QPS Respiratory & Allergy News - August, 2014
QPS Respiratory & Allergy News - February, 2014
QPS Engages in International Collaboration for Innovative Respiratory Research - November, 2013
Sophisticated Biomarkers, Including Gene Expression Profiling from Nasal Brushings, Sputum and Blood, Are Used in COPD Therapy Trial - November, 2013
Summer Update from the QPS Respiratory Team - August, 2013
Using Biomarker Analysis on Induced Sputum as a Measure of Primary Outcome in Asthma and COPD - April, 2013
Infectious Diseases QPS Hepatitis C Whitepaper Howard Schwartz, Medical Director of QPS Miami Research Associates Co-Authors Daclatasvir-Sofosbuvir Combination HCV Trial Published in The New England Journal Of Medicine - February, 2014
Dermatology QPS Transdermal Whitepaper Paul Lehman, QPS’ Vice President and Head of Dermal and Transdermal Research publishes Article on Assessing the Relative Bioavailability of Topical Clobetasol Propionate Products - August, 2014
QPS Dermal & Transdermal Brochure A randomized, double-blind, placebo-controlled clinical trial evaluating Dermytol® cream for the treatment of actinic keratoses
Paul A. Lehman, QPS’ Vice President and Head of Dermal and Transdermal Research Co-authors Book Chapter on Establishing the Bioequivalence (BE) of Topical Drug Products - February, 2014
QPS Announces Paul A. Lehman as New Vice President of Dermal and Transdermal Research Services - June, 2013
Female Healthcare QPS Female Healthcare Brochure Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results


20 years in pharma R&D navigation